222 related articles for article (PubMed ID: 24176052)
21. High prevalence of imipenem-resistant and metallo-beta-lactamase-producing Pseudomonas aeruginosa in the Burns Hospital in Tunisia: detection of a novel class 1 integron.
Chairat S; Ben Yahia H; Rojo-Bezares B; Sáenz Y; Torres C; Ben Slama K
J Chemother; 2019 May; 31(3):120-126. PubMed ID: 30849001
[TBL] [Abstract][Full Text] [Related]
22. Diversity of β-lactamases produced by imipenem resistant, Pseudomonas aeruginosa isolates from the bloodstream.
Najar Peerayeh S; Pirhajati Mahabadi R; Pakbaten Toupkanlou S; Siadat SD
Burns; 2014 Nov; 40(7):1360-4. PubMed ID: 24513132
[TBL] [Abstract][Full Text] [Related]
23. Pseudomonas aeruginosa bloodstream infections: risk factors and treatment outcome related to expression of the PER-1 extended-spectrum beta-lactamase.
Endimiani A; Luzzaro F; Pini B; Amicosante G; Rossolini GM; Toniolo AQ
BMC Infect Dis; 2006 Mar; 6():52. PubMed ID: 16542460
[TBL] [Abstract][Full Text] [Related]
24. Large dissemination of VIM-2-metallo-{beta}-lactamase-producing pseudomonas aeruginosa strains causing health care-associated community-onset infections.
Tsakris A; Poulou A; Kristo I; Pittaras T; Spanakis N; Pournaras S; Markou F
J Clin Microbiol; 2009 Nov; 47(11):3524-9. PubMed ID: 19776233
[TBL] [Abstract][Full Text] [Related]
25. Risk factors for nosocomial infections due to Pseudomonas aeruginosa producing metallo-beta-lactamase in two tertiary-care teaching hospitals.
Zavascki AP; Barth AL; Gaspareto PB; Gonçalves AL; Moro AL; Fernandes JF; Goldani LZ
J Antimicrob Chemother; 2006 Oct; 58(4):882-5. PubMed ID: 16895936
[TBL] [Abstract][Full Text] [Related]
26. Metallo-Beta-Lactamase Producing Pseudomonas aeruginosa in a Healthcare Setting in Alexandria, Egypt.
Abaza AF; El Shazly SA; Selim HSA; Aly GSA
Pol J Microbiol; 2017 Sep; 66(3):297-308. PubMed ID: 29319510
[TBL] [Abstract][Full Text] [Related]
27. Pseudomonas aeruginosa bacteraemia: independent risk factors for mortality and impact of resistance on outcome.
Dantas RC; Ferreira ML; Gontijo-Filho PP; Ribas RM
J Med Microbiol; 2014 Dec; 63(Pt 12):1679-1687. PubMed ID: 25261066
[TBL] [Abstract][Full Text] [Related]
28. Dissemination of genetically related IMP-6-producing multidrug-resistant Pseudomonas aeruginosa ST235 in South Korea.
Yoo JS; Yang JW; Kim HM; Byeon J; Kim HS; Yoo JI; Chung GT; Lee YS
Int J Antimicrob Agents; 2012 Apr; 39(4):300-4. PubMed ID: 22325122
[TBL] [Abstract][Full Text] [Related]
29. Bacteraemia due to extensively drug-resistant Pseudomonas aeruginosa sequence type 235 high-risk clone: Facing the perfect storm.
Recio R; Villa J; Viedma E; Orellana MÁ; Lora-Tamayo J; Chaves F
Int J Antimicrob Agents; 2018 Aug; 52(2):172-179. PubMed ID: 29621591
[TBL] [Abstract][Full Text] [Related]
30. First survey of metallo-beta-lactamases in clinical isolates of Pseudomonas aeruginosa in a German university hospital.
Valenza G; Joseph B; Elias J; Claus H; Oesterlein A; Engelhardt K; Turnwald D; Frosch M; Abele-Horn M; Schoen C
Antimicrob Agents Chemother; 2010 Aug; 54(8):3493-7. PubMed ID: 20498315
[TBL] [Abstract][Full Text] [Related]
31. Incidence of metallo beta lactamase producing Pseudomonas aeruginosa in ICU patients.
Varaiya A; Kulkarni N; Kulkarni M; Bhalekar P; Dogra J
Indian J Med Res; 2008 Apr; 127(4):398-402. PubMed ID: 18577797
[TBL] [Abstract][Full Text] [Related]
32. Emergence of Imipenem-Resistant Pseudomonas aeruginosa Clinical Isolates from Egypt Coharboring VIM and IMP Carbapenemases.
El-Domany RA; Emara M; El-Magd MA; Moustafa WH; Abdeltwab NM
Microb Drug Resist; 2017 Sep; 23(6):682-686. PubMed ID: 28085553
[TBL] [Abstract][Full Text] [Related]
33. Emergence of a New Delhi metallo-β-lactamase-1-producing Pseudomonas aeruginosa in Singapore.
Teo JW; La MV; Jureen R; Lin RT
Emerg Microbes Infect; 2015 Nov; 4(11):e72. PubMed ID: 26632659
[No Abstract] [Full Text] [Related]
34. Molecular epidemiology and clinical implications of metallo-β-lactamase-producing Pseudomonas aeruginosa isolated from urine.
Sako S; Kariyama R; Mitsuhata R; Yamamoto M; Wada K; Ishii A; Uehara S; Kokeguchi S; Kusano N; Kumon H
Acta Med Okayama; 2014; 68(2):89-99. PubMed ID: 24743784
[TBL] [Abstract][Full Text] [Related]
35. Description of IMP-31, a novel metallo-β-lactamase found in an ST235 Pseudomonas aeruginosa strain in Western Germany.
Pfennigwerth N; Geis G; Gatermann SG; Kaase M
J Antimicrob Chemother; 2015 Jul; 70(7):1973-80. PubMed ID: 25835992
[TBL] [Abstract][Full Text] [Related]
36. High prevalence of metallo-beta-lactamase-mediated resistance challenging antimicrobial therapy against Pseudomonas aeruginosa in a Brazilian teaching hospital.
Zavascki AP; Goldani LZ; Gonçalves AL; Martins AF; Barth AL
Epidemiol Infect; 2007 Feb; 135(2):343-5. PubMed ID: 16824253
[TBL] [Abstract][Full Text] [Related]
37. Molecular characterization of metallo-β-lactamase-producing Pseudomonas aeruginosa in a Czech hospital (2009-2011).
Papagiannitsis CC; Studentova V; Ruzicka F; Tejkalova R; Hrabak J
J Med Microbiol; 2013 Jun; 62(Pt 6):945-947. PubMed ID: 23493029
[No Abstract] [Full Text] [Related]
38. Unexpected mechanisms of resistance in Dutch Pseudomonas aeruginosa isolates collected during 14 years of surveillance.
Croughs PD; Klaassen CHW; van Rosmalen J; Maghdid DM; Boers SA; Hays JP; Goessens WHF;
Int J Antimicrob Agents; 2018 Sep; 52(3):407-410. PubMed ID: 29772393
[TBL] [Abstract][Full Text] [Related]
39. Molecular epidemiology of clinical Pseudomonas aeruginosa isolates carrying IMP-1 metallo-beta-lactamase gene in a University Hospital in Turkey.
Ozgumus OB; Caylan R; Tosun I; Sandalli C; Aydin K; Koksal I
Microb Drug Resist; 2007; 13(3):191-8. PubMed ID: 17949306
[TBL] [Abstract][Full Text] [Related]
40. Reduction of virulence factor pyocyanin production in multidrug-resistant Pseudomonas aeruginosa.
Fuse K; Fujimura S; Kikuchi T; Gomi K; Iida Y; Nukiwa T; Watanabe A
J Infect Chemother; 2013 Feb; 19(1):82-8. PubMed ID: 22865331
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
